These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 690438)

  • 1. Separate pathways of C activation by measles virus cytotoxic antibodies: subclass analysis and capacity of F(ab) molecules to activate C via the alternative pathway.
    Ehrnst A
    J Immunol; 1978 Sep; 121(3):1206-12. PubMed ID: 690438
    [No Abstract]   [Full Text] [Related]  

  • 2. Complement activation by measles virus cytotoxic antibodies: alternative pathway C activation by hemagglutination-inhibition antibodies but classical activation by hemolysin antibodies.
    Ehrnst AC
    J Immunol; 1977 Feb; 118(2):533-9. PubMed ID: 402419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative complement pathway-mediated lysis of measles virus infected cells: induction by IgG antibody bound to individual viral glycoproteins and comparative efficacy of F(ab')2 and Fab' fragments.
    Sissons JG; Cooper NR; Oldstone MB
    J Immunol; 1979 Nov; 123(5):2144-9. PubMed ID: 489977
    [No Abstract]   [Full Text] [Related]  

  • 4. Importance of the integrity of the inter-heavy-chain disulphide bond of rabbit IgG in the activation of the alternative pathway of human complement by the F(ab')2 region of rabbit IgG antibody in immune aggregates.
    Gadd KJ; Reid KB
    Immunology; 1981 Jan; 42(1):75-82. PubMed ID: 6780451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of measles virus-specific cytotoxic antibodies by use of a chronically infected cell line.
    Ehrnst AC
    J Immunol; 1975 Mar; 114(3):1077-82. PubMed ID: 1089724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologic injury of cultured cells infected with measles virus. I. role of IfG antibody and the alternative complement pathway.
    Joseph BS; Cooper NR; Oldstone MB
    J Exp Med; 1975 Apr; 141(4):761-74. PubMed ID: 1092789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of complement in viral infections. III. Activation of the classical and alternative complement pathways by Sindbis virus.
    Hirsch RL; Winkelstein JA; Griffin DE
    J Immunol; 1980 May; 124(5):2507-10. PubMed ID: 7365263
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralization of influenza virus by normal human sera: mechanisms involving antibody and complement.
    Beebe DP; Schreiber RD; Cooper NR
    J Immunol; 1983 Mar; 130(3):1317-22. PubMed ID: 6822737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of antibody and complement in lysing virus-infected cells.
    Sissons JG; Schreiber RD; Cooper NR; Oldstone MB
    Med Microbiol Immunol; 1982; 170(4):221-7. PubMed ID: 7048046
    [No Abstract]   [Full Text] [Related]  

  • 11. IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass pathway in a guinea pig model.
    Wagner E; Platt JL; Howell DN; Marsh HC; Frank MM
    J Immunol; 1999 Sep; 163(6):3549-58. PubMed ID: 10477630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on the interaction between cells infected with measles virus and anti-measles antibody. I. Cytotoxic antibody activity of sera obtained from patients with natural measles and subacute sclerosing panencephalitis by use of chronically infected cell lines].
    Kuwajima S
    Hokkaido Igaku Zasshi; 1986 Jan; 61(1):5-14. PubMed ID: 3699682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG on mouse erythrocytes augments activation of the human alternative complement pathway by enhancing deposition of C3b.
    Moore FD; Fearon DT; Austen KF
    J Immunol; 1981 May; 126(5):1805-9. PubMed ID: 6908606
    [No Abstract]   [Full Text] [Related]  

  • 14. Analysis of complement-dependent antibody-mediated lysis of target cells acutely infected with measles.
    Hicks JT; Klutch MJ; Albrecht P; Frank MM
    J Immunol; 1976 Jul; 117(1):208-15. PubMed ID: 819582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysis of measles virus-infected cells by the purified cytolytic alternative complement pathway and antibody.
    Patrick Sissons JG; Schreiber RD; Perrin LH; Cooper NR; Müller-Eberhard HJ; Oldstone MB
    J Exp Med; 1979 Sep; 150(3):445-54. PubMed ID: 479760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody restores human alternative complement pathway activation by mouse erythrocytes rendered functionally deficient by pretreatment with pronase.
    Moore FD; Austen KF; Fearon DT
    J Immunol; 1982 Mar; 128(3):1302-6. PubMed ID: 6915957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-density rafts preferentially host the complement activator measles virus F glycoprotein but not the regulators of complement activation.
    Ghannam A; Hammache D; Matias C; Louwagie M; Garin J; Gerlier D
    Mol Immunol; 2008 Jun; 45(11):3036-44. PubMed ID: 18455798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Complement fixation ability of precipitating and co-precipitating antibodies of various animal species].
    Perdigón G; Gentile T; Margni A
    Rev Argent Microbiol; 1979; 11(1):1-6. PubMed ID: 538236
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of C2-associated carbohydrate structure on Ig effector function: studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells.
    Wright A; Morrison SL
    J Immunol; 1998 Apr; 160(7):3393-402. PubMed ID: 9531299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-mediated cytotoxicity after measles virus infection.
    Kibler R; Meulen VT
    J Immunol; 1975 Jan; 114(1 Pt 1):93-8. PubMed ID: 803529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.